US Patent Issued on July 29 for "Exosome assay for depression and psychosis and methods and agents for treating depression, psychosis and schizophrenia" (California Inventor)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,372,538, issued on July 29.

"Exosome assay for depression and psychosis and methods and agents for treating depression, psychosis and schizophrenia" was invented by Edward J Goetzl (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to exosomal complement mediators, cytokines, and mitochondrial electron transport biomarkers and diagnostic and prognostic methods for depression, psychosis and schizophrenia. The disclosure also provides compositions for detecting exosomal complement mediators, cytokines, and mitochondrial electron transport biomarkers in biological samples as well as compositions and methods useful ...